OPNT - Opiant Pharmaceuticals GAAP EPS of -$2.43 misses by $1.68 revenue of $4.47M misses by $1.43M May, 10 2022 04:09 PM Opiant Pharmaceuticals Inc. Opiant Pharmaceuticals press release (NASDAQ:OPNT): Q1 GAAP EPS of -$2.43 misses by $1.68. Revenue of $4.47M (-30.0% Y/Y) misses by $1.43M. For further details see: Opiant Pharmaceuticals GAAP EPS of -$2.43 misses by $1.68, revenue of $4.47M misses by $1.43M